SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-013601
Filing Date
2019-03-13
Accepted
2019-03-13 08:06:15
Documents
77
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F tv515440_20f.htm 20-F 1633268
2 EXHIBIT 4.9 tv515440_ex4-9.htm EX-4.9 10148
3 EXHIBIT 8.1 tv515440_ex8-1.htm EX-8.1 3092
4 EXHIBIT 12.1 tv515440_ex12-1.htm EX-12.1 7877
5 EXHIBIT 12.2 tv515440_ex12-2.htm EX-12.2 7862
6 EXHIBIT 13.1 tv515440_ex13-1.htm EX-13.1 5515
7 EXHIBIT 15.1 tv515440_ex15-1.htm EX-15.1 2988
14 GRAPHIC ex4x9_001.jpg GRAPHIC 103749
15 GRAPHIC ex4x9_002.jpg GRAPHIC 129558
16 GRAPHIC ex4x9_003.jpg GRAPHIC 143958
17 GRAPHIC ex4x9_004.jpg GRAPHIC 157734
18 GRAPHIC tv515440_img01.jpg GRAPHIC 45118
19 GRAPHIC tv515440_img02.jpg GRAPHIC 33519
20 GRAPHIC tv515440_img03.jpg GRAPHIC 87700
21 GRAPHIC tv515440_img04.jpg GRAPHIC 112201
22 GRAPHIC tv515440_img05.jpg GRAPHIC 9262
23 GRAPHIC tv515440_img06.jpg GRAPHIC 34595
  Complete submission text file 0001144204-19-013601.txt   7759559

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT glmd-20181231.xml EX-101.INS 1649606
9 XBRL TAXONOMY EXTENSION SCHEMA glmd-20181231.xsd EX-101.SCH 34590
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE glmd-20181231_cal.xml EX-101.CAL 40424
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE glmd-20181231_def.xml EX-101.DEF 203251
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE glmd-20181231_lab.xml EX-101.LAB 271693
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glmd-20181231_pre.xml EX-101.PRE 261275
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36345 | Film No.: 19677131
SIC: 2834 Pharmaceutical Preparations